NCT00097084 - Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart in Type 2 Diabetes | Biotech Hunter

Enrollment

324

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

insulin detemir

DRUG

insulin glargine

DRUG

insulin aspart

Trial Locations (60)

1723

Novo Nordisk Investigational Site, Sarpsborg

4011

Novo Nordisk Investigational Site, Stavanger

11108

Novo Nordisk Investigational Site, Narbonne

16148

Novo Nordisk Investigational Site, Hermitage

19107

Novo Nordisk Investigational Site, Philadelphia

20700

Novo Nordisk Investigational Site, Turku

23249

Novo Nordisk Investigational Site, Richmond

23606

Novo Nordisk Investigational Site, Newport News

28803

Novo Nordisk Investigational Site, Asheville

29200

Novo Nordisk Investigational Site, Brest

30606

Novo Nordisk Investigational Site, Athens

32216

Novo Nordisk Investigational Site, Jacksonville

32746

Novo Nordisk Investigational Site, Lake Mary

32804

Novo Nordisk Investigational Site, Orlando

32901

Novo Nordisk Investigational Site, Melbourne

32960

Novo Nordisk Investigational Site, Vero Beach

33433

Novo Nordisk Investigational Site, Boca Raton

34295

Novo Nordisk Investigational Site, Montpellier

34684

Novo Nordisk Investigational Site, Palm Harbor

58033

Novo Nordisk Investigational Site, Nevers

66606

Novo Nordisk Investigational Site, Topeka

68114

Novo Nordisk Investigational Site, Omaha

69200

Novo Nordisk Investigational Site, Vénissieux

72204

Novo Nordisk Investigational Site, Little Rock

75181

Novo Nordisk Investigational Site, Paris

75235

Novo Nordisk Investigational Site, Dallas

75246

Novo Nordisk Investigational Site, Dallas

78229

Novo Nordisk Investigational Site, San Antonio

90301

Novo Nordisk Investigational Site, Inglewood

91978

Novo Nordisk Investigational Site, Spring Valley

92014

Novo Nordisk Investigational Site, Nanterre

92705

Novo Nordisk Investigational Site, Santa Ana

98405

Novo Nordisk Investigational Site, Tacoma

94143-0780

Novo Nordisk Investigational Site, San Francisco

83404-7596

Novo Nordisk Investigational Site, Idaho Falls

89119-6100

Novo Nordisk Investigational Site, Las Vegas

08009

Novo Nordisk Investigational Site, Berlin

75390-8858

Novo Nordisk Investigational Site, Dallas

02740

Novo Nordisk Investigational Site, Espoo

00260

Novo Nordisk Investigational Site, Helsinki

FI-61300

Novo Nordisk Investigational Site, Kurikka

FI-15110

Novo Nordisk Investigational Site, Lahti

FI-62100

Novo Nordisk Investigational Site, Lapua

FI-90220

Novo Nordisk Investigational Site, Oulu

Unknown

Novo Nordisk Investigational Site, Le Mans

Novo Nordisk Investigational Site, Orléans

NO-5009

Novo Nordisk Investigational Site, Bergen

NO-3675

Novo Nordisk Investigational Site, Notodden

NO-1400

Novo Nordisk Investigational Site, Ski

NO-7030

Novo Nordisk Investigational Site, Trondheim

262 91

Novo Nordisk Investigational Site, Ängelholm

791 82

Novo Nordisk Investigational Site, Falun

417 17

Novo Nordisk Investigational Site, Gothenburg

391 85

Novo Nordisk Investigational Site, Kalmar

221 85

Novo Nordisk Investigational Site, Lund

223 70

Novo Nordisk Investigational Site, Lund

214 26

Novo Nordisk Investigational Site, Malmo

591 85

Novo Nordisk Investigational Site, Motala

572 28

Novo Nordisk Investigational Site, Oskarshamn

451 50

Novo Nordisk Investigational Site, Uddevalla